Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Eleven genomic loci affect plasma levels of chronic inflammation marker soluble urokinase-type plasminogen activator receptor

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Large genome-wide association study identifies three novel risk variants for restless legs syndrome

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Data Resource Profile: The Copenhagen Hospital Biobank (CHB)

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. A novel homozygous GFI1B variant in 2 sisters with thrombocytopenia and severe bleeding tendency

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Twenty-five years of triptans - a nationwide population study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Validation of a standardized donor health questionnaire across substances of human origin

    Research output: Contribution to journalJournal articleResearchpeer-review

  • DBDS Genomic Consortium
View graph of relations

Soluble urokinase-type plasminogen activator receptor (suPAR) is a chronic inflammation marker associated with the development of a range of diseases, including cancer and cardiovascular disease. The genetics of suPAR remain unexplored but may shed light on the biology of the marker and its connection to outcomes. We report a heritability estimate of 60% for the variation in suPAR and performed a genome-wide association meta-analysis on suPAR levels measured in Iceland (N = 35,559) and in Denmark (N = 12,177). We identified 13 independently genome-wide significant sequence variants associated with suPAR across 11 distinct loci. Associated variants were found in and around genes encoding uPAR (PLAUR), its ligand uPA (PLAU), the kidney-disease-associated gene PLA2R1 as well as genes with relations to glycosylation, glycoprotein biosynthesis, and the immune response. These findings provide new insight into the causes of variation in suPAR plasma levels, which may clarify suPAR's potential role in associated diseases, as well as the underlying mechanisms that give suPAR its prognostic value as a unique marker of chronic inflammation.

Original languageEnglish
JournalCommunications biology
Volume4
Issue number1
Pages (from-to)655
ISSN2399-3642
DOIs
Publication statusPublished - 2 Jun 2021

ID: 66131583